PDGFRB and Increased total eosinophil count: Cases of AML with PDGFRA, PDGFRΒ, and FGFR1 rearrangements are included in the current WHO classification in the broad category of “myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions” [24].